Is Sorafenib an Optimal Treatment for Hepatocellular Carcinoma With Macrovascular Invasion or Metastatic Disease?

Hepatology - United States
doi 10.1002/hep.29862
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Safety and Efficacy of Transcatheter Arterial Chemoembolization Plus Radiotherapy Combined With Sorafenib in Hepatocellular Carcinoma Showing Macrovascular Invasion

Frontiers in Oncology
Cancer ResearchOncology
2019English

Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Optimal Postoperative Adjuvant Treatment Strategy for HBV-related Hepatocellular Carcinoma With Microvascular Invasion: A Propensity Score Analysis

OncoTargets and Therapy
OncologyPharmacology
2019English

Successful Treatment of Hepatocellular Carcinoma With Regorafenib After Sorafenib-Induced Hypersensitivity

Internal Medicine
Internal MedicineMedicine
2019English

Sorafenib in Hepatocellular Carcinoma

Clinical Medicine. Therapeutics
2009English

Advanced Recurrent Hepatocellular Carcinoma: Treatment With Sorafenib Alone or in Combination With Transarterial Chemoembolization and Radiofrequency Ablation

Radiology
Nuclear MedicineRadiologyImaging
2018English

An Osteopontin Fragment Is Essential for Tumor Cell Invasion in Hepatocellular Carcinoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Medium or Large Hepatocellular Carcinoma: Sorafenib Combined With Transarterial Chemoembolization and Radiofrequency Ablation

Radiology
Nuclear MedicineRadiologyImaging
2018English

Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma

Journal of Liver Research, Disorders & Therapy
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy